{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:08:55Z","timestamp":1648724935961},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":2879,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.anpedi.2010.08.012","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T10:21:58Z","timestamp":1285755718000},"page":"31-37","source":"Crossref","is-referenced-by-count":0,"title":["An\u00e1lisis de GATA1 en los trastornos mieloproliferativos asociados a la trisom\u00eda 21"],"prefix":"10.1016","volume":"74","author":[{"given":"J.L.","family":"Fuster Soler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Galera Mi\u00f1arro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Berm\u00fadez Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Llinares Riestra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ortu\u00f1o Giner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2010.08.012_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pbc.20066","article-title":"GATA1 Mutations in Down Syndrome: Implications for Biology and Diagnosis of Children With Transient Myeloproliferative Disorder and Acute Megakaryoblastic Leukemia","volume":"44","author":"Crispino","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpedi.2010.08.012_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.earlhumdev.2006.09.016","article-title":"Down myeloid disorders: A paradigm for childhood preleukemia and leukaemia and insights into normal megakaryopoiesis","volume":"82","author":"Vyas","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.anpedi.2010.08.012_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2009.07789.x","article-title":"Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis","volume":"147","author":"Roy","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib4","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","volume":"15","author":"Massey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib5","first-page":"608","article-title":"Distinctive Demography, Biology, and Outcome of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Children with Down Syndrome: Children's Cancer Group Studies 2861 and 2891","volume":"91","author":"Lange","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1525","article-title":"Origins of leukemia in children with Down syndrome","volume":"5","author":"Hitzler","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anpedi.2010.08.012_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05700.x","article-title":"Optimizing therapy for myeloid disorders of Down syndrome","volume":"131","author":"Webb","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pbc.20207","article-title":"Acute Myeloid Leukemia and Down Syndrome Evolution of Modern Therapy-Sate of the Art Review","volume":"44","author":"Gamis","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpedi.2010.08.012_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2141.2006.06097.x","article-title":"Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome","volume":"133","author":"Al-Ahmari","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10428190500485810","article-title":"Transcription factor GATA-1 and Down syndrome leukemogenesis","volume":"47","author":"Muntean","year":"2006","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.anpedi.2010.08.012_bib11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.leu.2403814","article-title":"AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.anpedi.2010.08.012_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00277-005-0045-5","article-title":"Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature","volume":"85","author":"Abildgaard","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2005.05906.x","article-title":"Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials","volume":"132","author":"Rao","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib14","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1200\/JCO.2007.12.3687","article-title":"Prospective Study of a Pirarubicin, Intermediate-Dose Cytarabine, and Etoposide Regimen, in Children With Down Syndrome and Acute Myeloid Leukemia: The Japanese Childhood AML Cooperative Study Group","volume":"25","author":"Kudo","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2007.06971.x","article-title":"Acute megakarioblastic leucemia (AMKL) in children: a comparison of AMKL with and without Down syndrome","volume":"140","author":"Hama","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib16","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","article-title":"Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome","volume":"113","author":"Malinge","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOP.0b013e328013e7b2","article-title":"Molecular insights into Down syndrome-associated leukaemia","volume":"19","author":"Vyas","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anpedi.2010.08.012_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2003-05-1556","article-title":"Recent insights into the mechanism of myeloid leukemogenesis in Down syndrome","volume":"103","author":"Gurbuxani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib19","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/blood-2003-01-0013","article-title":"GATA1 mutations in transient leukemia and acute megakarioblastic leukemia of Down syndrome","volume":"101","author":"Hitzler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.leukres.2005.04.007","article-title":"GATA1 as a new target to detect minimal residual disease in both transient leukaemia and megakaryoblastic leukaemia of Down syndrome","volume":"29","author":"Pine","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.anpedi.2010.08.012_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukaemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.anpedi.2010.08.012_bib22","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","article-title":"Increased Age at Diagnosis Has a Singnificantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children's Cancer Group Study 2891","volume":"21","author":"Gamis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib23","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidente and clinical implications of GATA1 mutations in newborns with Down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cancergencyto.2005.10.008","article-title":"GATA1 mutations in acute leukaemia in children with Down syndrome","volume":"166","author":"Magalh\u00e3es","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anpedi.2010.08.012_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrc2348","article-title":"GATA1-related leukemias","volume":"8","author":"Shimizu","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anpedi.2010.08.012_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng1825","article-title":"An inherited mutation leading to the production of only the short isoform of GATA-1 is associated with impaired erythropoiesis","volume":"38","author":"Hollanda","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.anpedi.2010.08.012_bib27","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1182\/blood-2004-01-0016","article-title":"The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome","volume":"103","author":"Harigae","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2010.08.012_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng0706-741","article-title":"GATA1s goes germline","volume":"38","author":"Mundschau","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.anpedi.2010.08.012_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1309\/XREF-C9T2-6U0A-4EDT","article-title":"Transient Myeloproliferative Disorder and Acute Myeloid Leukemia in Down Syndrome","volume":"116","author":"Karandikar","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anpedi.2010.08.012_bib30","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.jpeds.2006.10.055","article-title":"Down syndrome and GATA1-related transient leukaemia","volume":"150","author":"Sandoval","year":"2007","journal-title":"J Pediatr"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310003747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310003747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T19:56:51Z","timestamp":1544212611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403310003747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1695403310003747"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2010.08.012","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}